News

  • Dr. Peter Neubeck speaks at BIO-Europe Conference

    04.11.2016 – Dr. Peter Neubeck, Chief Medical Officer at ExB, is invited to speak at BIO-Europe in Cologne. BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. Dr. Neubeck will be talking at the panel discussion”Big Pharma’s approach to digital medicine” on Monday Nov 7. The convergence of new technologies and therapies…

    Read more
  • ExB represents Big Data Application in Biotech for Bavaria

    18.07.2016 – ExB was invited to the Zukunftsrat der Bayerischen Wirtschaft, an official council of the state of Bavaria to define and shape the economic future of Bavaria. The focus was on big data applications in a digital future and ExB was selected to represent the feature application in Biotechnology.…

    Read more
  • ExB at the DLD-Conference in New York

    28 April 2016 The DLD NYC 16 conference, taking place May 3rd and 4th in New York, is bringing together digital natives, creators and enablers from Europe, Israel and the United States. The conference has invited ExB CEO Ramin Assadollahi to speak about Artificial Intelligence followed by David Kenny, IBM…

    Read more
  • Research Hospital Charité using ExB Technology to study Fibrosis treatments

    24. April 2016 Berlin-based university hospital Charité is using cutting edge ExB technologies in its fibrosis research, in order to automate the analysis of tissue sections for early recognition of pathological changes. Doctor-performed histopathological analysis of liver biopsy samples is currently the gold standard for fibrosis, but is also very…

    Read more
  • ExB Celebrates Success at International Competitions

    16. April 2016 ExB’s top-tier results in the Camelyon Challenge at ISBI 2016 proves that its image analysis technology is able to handle extremely complex diagnostic tasks. The technology compared systems for identifying cancer in lymph node sections in two tasks. ExB ranked overall second out of 23 participants, drawn…

    Read more